$8.50 -0.14 (-1.62%)
11/27/2009 1:00 PM

Boston Scientific Corp. (BSX)

CAPS Rating: 3 out of 5

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

Results 1 - 20 of 183 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar 1955Cowboy (33.43) Submitted: 4/3/2008 6:51:11 PM : Outperform Start Price: $13.58 BSX Score: -20.57

Boston Scientific Corp has been around for many years and a good buy for me. this is the time to buy.

Recs

0
Member Avatar 1jeshua (32.68) Submitted: 10/11/2006 2:40:19 AM : Outperform Start Price: $15.19 BSX Score: -30.29

BSX has finally bottomed out, slow and steady climb back to $30.

Recs

4
Member Avatar 1ld (49.29) Submitted: 11/19/2008 5:58:20 AM : Outperform Start Price: $7.30 BSX Score: -14.41

way undervalued

Recs

0
Member Avatar 5761 (< 20) Submitted: 10/22/2007 9:13:26 AM : Outperform Start Price: $14.29 BSX Score: -17.63

finally cleaning up expenses and head count which should have been done 12 months ago. Management was a little slow in getting started but they seem to "get it" now. Debt will come down and non strategic businesses will be sold. Coated stents will slowly recover market. Main issue left to resolve is FDA letter.

Recs

0
Member Avatar agentjj (< 20) Submitted: 10/12/2006 3:51:01 PM : Outperform Start Price: $15.44 BSX Score: -30.01

can only go up

Recs

15
Member Avatar aheadofthebell (< 20) Submitted: 10/2/2008 1:44:44 PM : Underperform Start Price: $11.29 BSX Score: +24.44

Boston Scientific was cut to underperform from neutral by Merrill Lynch, citing lower absolute returns relative to rivals, worries over market share and the challenge in marketing two competing drug eluting stent platforms.

Recs

2
Member Avatar alolio (< 20) Submitted: 10/20/2006 1:30:16 AM : Underperform Start Price: $16.10 BSX Score: +32.15

Drowning in debt. High turnover for field employees. CRM division can't release products and continually becomes less competitive in the ICD market decline that they started. Yes, I am biased.

Recs

16
Member Avatar alottadick (< 20) Submitted: 10/9/2008 9:15:31 AM : Underperform Start Price: $9.80 BSX Score: +26.11

Future earnings are looking very bleak, the competiton has beaten them up and thye are trying to survive with very little capital. Look for worse times to come..

Recs

16
Member Avatar analyzer2008 (< 20) Submitted: 8/14/2008 8:30:46 AM : Underperform Start Price: $13.30 BSX Score: +24.50

The Cleveland Clinic is putting drug-coated stents from multiple suppliers in its cardiologists' hands for the next year to let doctors try the latest devices, but it appears industry heavyweight Boston Scientific Corp. isn't in the mix.

Recs

4
Member Avatar askapro (< 20) Submitted: 11/20/2008 9:50:07 AM : Underperform Start Price: $6.21 BSX Score: +5.30

Skip taking a chance with this company. They have lost all integrity and are about to pay the ultimate price.

Recs

0
Member Avatar barney1834 (57.14) Submitted: 11/20/2009 11:43:36 AM : Outperform Start Price: $8.14 BSX Score: +4.09

Going to be giving this one a very optimistic forecast over the winter. Profit last quarter would have been up considerably had they not had to pay out the settlement - now that that's over and accounted for it's looking less bleak.

Recs

3
Member Avatar beatthemarket2 (< 20) Submitted: 11/24/2008 3:04:06 PM : Underperform Start Price: $5.94 BSX Score: -11.02

Insiders are cashing out on this turkey. I would take this as a serious wake up call and sell, sell, sell !!!

Recs

0
Member Avatar belgianbrains (45.97) Submitted: 1/19/2007 4:31:44 PM : Outperform Start Price: $18.09 BSX Score: -34.30

Important player in a domain which is destinated to grow, seen the aging population of the western countries.

Recs

16
Member Avatar bestpixs (< 20) Submitted: 10/1/2008 2:20:06 PM : Underperform Start Price: $11.09 BSX Score: +20.17

Another big debt of 703 million added to the 300 million dollar hole they are already in. This company is starting to sound like the national debt. I need no more convincing that this was a bad, bad, bad investment. Holy SHi#$&& I just lost another $2780 while I was writing this comment. Time to call my broker and sell. Gotta go......

Recs

0
Member Avatar bighorse4 (< 20) Submitted: 11/17/2006 3:02:53 PM : Outperform Start Price: $16.16 BSX Score: -30.47

stents are hot. Plus Cramer likes it. Enough not said, but I still like it.

Recs

1
Member Avatar bigreenmountain (< 20) Submitted: 10/4/2006 4:40:02 AM : Outperform Start Price: $15.90 BSX Score: -37.49

They've done everything but shoot BSX in the heart and install one of its own stints. It's at it's lowest PE ever and insiders are snatching it up. I say it's a bargain.

Recs

9
Member Avatar biotechnerd (< 20) Submitted: 11/5/2008 9:05:01 AM : Underperform Start Price: $8.83 BSX Score: +17.03

Bio-technology in the next 5 years will doom all these type of devices made by Boston Scientific.

Recs

0
Member Avatar bluesinjid (57.98) Submitted: 10/20/2009 5:13:09 PM : Outperform Start Price: $8.54 BSX Score: -0.95

Watching stock, dipping and now buying with real cash ;)

Recs

0
Member Avatar bmadoff (< 20) Submitted: 4/28/2009 9:16:33 AM : Underperform Start Price: $8.21 BSX Score: +26.76

This is an excellent Bernie Madoff invetsment, I can think of no better way to lose all your money.

Recs

1
Member Avatar brainshred (80.56) Submitted: 2/19/2007 3:15:31 PM : Underperform Start Price: $17.00 BSX Score: +29.90

OVER PRICED

Featured Broker Partners